Related Experiment Video
Updated: Jun 9, 2026
08:09
Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
Published on: July 25, 2017
Endometrial cancer--prospective potential to make diagnostic process more specific
Vanda Repiska1, Edward Radzo, Czaba Biro
1Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovakia.
Neuro Endocrinology Letters
|August 31, 2010
Summary
TP53 gene mutations are linked to endometrial cancer. A specific TP53 gene polymorphism was found in all precancerous lesions and endometrial carcinomas, aiding diagnosis and potentially improving patient outcomes.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Endometrial carcinoma incidence is rising in younger patients.
- Tumor suppressor gene TP53 mutations are implicated in endometrial carcinogenesis.
Purpose of the Study:
- To investigate the role of TP53 gene mutations in endometrial carcinogenesis.
- To identify specific TP53 gene alterations in endometrial precancerous lesions and carcinomas.
Main Methods:
- Exons 2-11 of the TP53 gene were analyzed using DNA sequencing and restriction analysis.
- Tissues from endometrial carcinoma and precancerous lesions were examined.
Main Results:
- A CCC/CGC polymorphism at codon 72 in exon 4 of the TP53 gene was identified.
- This polymorphism was present in all analyzed precancerous lesions and endometrial carcinomas.
Conclusions:
- The findings suggest TP53 gene alterations are crucial in endometrial carcinogenesis.
- Identifying specific TP53 polymorphisms can enhance diagnostic specificity for endometrial cancer, including serous histological types.
- DNA analysis holds potential for improving adjuvant therapy and patient survival rates.
